BIOCON.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Stats
本日の出来高	9.28M
平均出来高	8.30M
時価総額	368.58B
EPS	INR0 ( 2024-02-08 )
次の収益日	( INR1.300 ) 2024-05-16
Last Dividend	INR1.500 ( 2023-07-06 )
Next Dividend	INR0 ( N/A )
P/E	30.61
ATR14	INR0.303 (0.10%)

ボリューム相関

長: 0.36 (neutral)

短: 0.27 (neutral)

Signal:(61.619) Neutral

Biocon Limited 相関

10 最も正の相関
APLLTD.NS	0.953
MSUMI.NS	0.946
IMPEXFERRO.NS	0.943
NAVNETEDUL.NS	0.942
LICNFNHGP.NS	0.938
TATACONSUM.NS	0.935
TATACOFFEE.NS	0.933
ICICI500.NS	0.93
ENIL.NS	0.929
ICICINF100.NS	0.929

10 最も負の相関
4THDIM.NS	-0.948
JSL.NS	-0.925
LTGILTBEES.NS	-0.908
RAJRILTD.NS	-0.906
ISMTLTD.NS	-0.9
KIRLFER.NS	-0.876
JSLHISAR.NS	-0.869
SUNFLAG.NS	-0.864
OIL.NS	-0.86
DFMFOODS.NS	-0.859

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Biocon Limited 相関 - 通貨/商品

-0.39
( neutral )

-0.29
( neutral )

0.55
( weak )

0.14
( neutral )

-0.84
( strong negative )

-0.89
( strong negative )

Biocon Limited 財務諸表

Annual	2022
収益:	INR111.74B
総利益:	INR75.11B (67.22 %)
EPS:	INR3.88

FY	2022
収益:	INR111.74B
総利益:	INR75.11B (67.22 %)
EPS:	INR3.88

FY	2022
収益:	INR80.25B
総利益:	INR53.01B (66.06 %)
EPS:	INR5.44

FY	2021
収益:	INR69.70B
総利益:	INR47.60B (68.29 %)
EPS:	INR6.24

Financial Reports:

No articles found.

Biocon Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Biocon Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 6.47 - average (82.41%) | Divividend Growth Potential Score: 2.72 - Decrease likely (45.56%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.0833	2004-07-01
Last Dividend	INR1.500	2023-07-06
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	INR10.21	--
Avg. Dividend % Per Year	0.18%	--
Score	1.84	--
Div. Sustainability Score	6.47
Div.Growth Potential Score	2.72
Div. Directional Score	4.59	--

Next Divdend (Est)
(2024-06-14)

INR1.691 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.84

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.500	0.16%
2019	INR0.500	0.16%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0.500	0.14%
2023	INR1.500	0.57%
2024	INR0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TNPETRO.NS	Dividend Junior	2023-09-18	Sporadic	23	2.02%
PFIZER.NS	Dividend Junior	2023-08-11	Annually	22	0.82%
JAYBARMARU.NS	Dividend Junior	2023-09-08	Annually	23	1.48%
DCMSHRIRAM.NS	Dividend Junior	2023-07-18	Semi-Annually	23	1.23%
SIYSIL.NS	Dividend Junior	2023-07-24	Semi-Annually	18	1.37%
MEDICAMEQ.NS	Ex Dividend Junior	2023-09-20	Annually	3	0.02%
GULFOILLUB.NS	Dividend Junior	2023-08-25	Annually	11	2.19%
BBTC.NS	Dividend Junior	2023-09-22	Annually	22	0.08%
PRESTIGE.NS	Dividend Junior	2023-09-14	Annually	14	0.25%
KANSAINER.NS	Dividend Junior	2023-05-25	Annually	21	0.49%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0845	1.500	8.31	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0216	1.200	9.28	10.00	[0 - 0.3]
returnOnEquityTTM	0.0636	1.500	-0.404	-0.606	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.104	0.800	9.48	7.59	[1 - 3]
quickRatioTTM	0.627	0.800	-1.018	-0.814	[0.8 - 2.5]
cashRatioTTM	0.135	1.500	-0.359	-0.539	[0.2 - 2]
debtRatioTTM	0.291	-1.500	5.16	-7.74	[0 - 0.6]
interestCoverageTTM	2.65	1.000	-0.128	-0.128	[3 - 30]
operatingCashFlowPerShareTTM	20.50	2.00	3.17	6.33	[0 - 30]
freeCashFlowPerShareTTM	20.50	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.817	-1.500	6.73	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.662	1.000	2.29	2.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.186	1.000	8.28	8.28	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.153	1.000	-0.264	-0.264	[0.2 - 2]
assetTurnoverTTM	0.256	0.800	-1.628	-1.302	[0.5 - 2]
Total Score				6.47

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.35	1.000	7.04	0	[1 - 100]
returnOnEquityTTM	0.0636	2.50	-0.260	-0.606	[0.1 - 1.5]
freeCashFlowPerShareTTM	20.50	2.00	3.17	10.00	[0 - 30]
dividendYielPercentageTTM	0.494	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	20.50	2.00	3.17	6.33	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-23.98	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.173	1.000	8.17	0	[0.1 - 0.5]
Total Score				2.72

Biocon Limited

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.